SCHEMBL2002948

SCHEMBL2002948

O=C(CN1C(=O)CCC1=O)OBr

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
ALOX12 P18054 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.40
RAB9A P51151 1/20 0.40
HPGD P15428 1/20 0.38
GAA P10253 2/20 0.38
POLB P06746 1/20 0.38
TSHR P16473 1/20 0.38
LMNA P02545 3/20 0.37
FGF2 P09038 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM4E B2RXH2 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
G6PD P11413 1/20 0.35
HTT P42858 1/20 0.35
GFER P55789 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7796008 0.80 RAB9A (0.41) ALDH1A1ALOX12SMN1; SMN2RAB9AHPGD
SCHEMBL2754581 0.78 ALDH1A1 (0.49) ALDH1A1ALOX12SMN1; SMN2RAB9AHPGD
SCHEMBL668458 0.78 RAB9A (0.40) ALDH1A1ALOX12SMN1; SMN2RAB9AHPGD
SCHEMBL13895524 0.77 RAB9A (0.39) ALDH1A1ALOX12SMN1; SMN2RAB9AHPGD
SCHEMBL18825277 0.75 GSK3A (0.61) ALDH1A1RAB9ALMNANPSR1MEN1
SCHEMBL9532098 0.74 PLA2G10 (0.40) ALDH1A1SMN1; SMN2RAB9AHPGDPOLB
SCHEMBL4671579 0.74 ALDH1A1 (0.39) ALDH1A1ALOX12SMN1; SMN2RAB9AHPGD
SCHEMBL22147439 0.74 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2RAB9AHPGDGAA
SCHEMBL3254635 0.74 RAB9A (0.37) ALDH1A1ALOX12SMN1; SMN2RAB9AHPGD
SCHEMBL236431 0.72 TSHR (0.56) ALDH1A1ALOX12SMN1; SMN2RAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1701968-A4 IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME WYETH CORP (US) 2007-10-03 EP claimed
EP-1701968-A2 IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME Wyeth (US) 2006-09-20 EP claimed
EP-1699810-A2 A BETA IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME Elan Pharmaceuticals, Inc. (US) 2006-09-13 EP claimed
WO-2005058941-A2 Aβ IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME ELAN PHARMACEUTICALS, INC. (US) 2005-06-30 WO claimed
WO-2005058940-A2 IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME WYETH (US) 2005-06-30 WO claimed
EP-2479184-A2 Beta immunogenic peptide carrier conjugates and methods of producing the same Janssen Alzheimer Immunotherapy (IE) 2012-07-25 EP disclosed
EP-2460813-A1 A beta immunogenic peptide carrier conjugates and methods of producing same Janssen Alzheimer Immunotherapy (IE) 2012-06-06 EP disclosed
EP-2336147-A2 A beta immunogenic peptide carrier conjugates and methods of producing same Janssen Alzheimer Immunotherapy (IE) 2011-06-22 EP disclosed
WO-2006026754-A9 BICYCLIC HETEROARYL PDE4B INHIBITORS PLEXXIKON INC (US) 2006-04-20 WO disclosed
EP-0847528-A1 MAGNETIC NANOPARTICLES COUPLED TO ANNEXINE, AND UTILIZATION THEREOF UNIVERSITE PIERRE ET MARIE CURIE PARIS VI (FR) 1998-06-17 EP disclosed
WO-1997001760-A1 MAGNETIC NANOPARTICLES COUPLED TO ANNEXINE, AND UTILIZATION THEREOF UNIVERSITE PIERRE ET MARIE CURIE (PARIS VI) (FR) 1997-01-16 WO disclosed